AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) Short Interest Update

AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) was the target of a significant drop in short interest in the month of September. As of September 15th, there was short interest totaling 56,901 shares, a drop of 53.5% from the August 31st total of 122,409 shares. Approximately 2.5% of the shares of the stock are sold short. Based on an average trading volume of 35,542 shares, the days-to-cover ratio is currently 1.6 days.

AdvisorShares Psychedelics ETF Price Performance

Shares of AdvisorShares Psychedelics ETF stock traded down $0.24 during trading hours on Tuesday, hitting $22.90. The company’s stock had a trading volume of 87,559 shares, compared to its average volume of 34,525. The business has a 50 day moving average price of $24.75 and a two-hundred day moving average price of $21.66. AdvisorShares Psychedelics ETF has a 12-month low of $15.63 and a 12-month high of $27.02.

Institutional Inflows and Outflows

An institutional investor recently bought a new stake in AdvisorShares Psychedelics ETF stock. Vigilare Wealth Management acquired a new stake in shares of AdvisorShares Psychedelics ETF (NYSEARCA:PSIL) in the second quarter, according to its most recent disclosure with the SEC. The firm acquired 8,800 shares of the company’s stock, valued at approximately $212,000. Vigilare Wealth Management owned approximately 0.47% of AdvisorShares Psychedelics ETF at the end of the most recent reporting period.

AdvisorShares Psychedelics ETF Company Profile

The AdvisorShares Psychedelics ETF (PSIL) is an exchange-traded fund that mostly invests in health care equity. The fund is actively managed to provide exposure to the emerging global psychedelics industry. PSIL was launched on Sep 15, 2021 and is managed by AdvisorShares.